GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » Quick Ratio
中文

Orphazyme AS (OCSE:ORPHA) Quick Ratio : 5.73 (As of Jun. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Orphazyme AS Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Orphazyme AS's quick ratio for the quarter that ended in Jun. 2022 was 5.73.

Orphazyme AS has a quick ratio of 5.73. It generally indicates good short-term financial strength.

The historical rank and industry rank for Orphazyme AS's Quick Ratio or its related term are showing as below:

OCSE:ORPHA's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.56
* Ranked among companies with meaningful Quick Ratio only.

Orphazyme AS Quick Ratio Historical Data

The historical data trend for Orphazyme AS's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Quick Ratio Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Quick Ratio
Get a 7-Day Free Trial 13.75 7.99 2.25 4.70 1.23

Orphazyme AS Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.24 4.70 1.80 1.23 5.73

Competitive Comparison of Orphazyme AS's Quick Ratio

For the Biotechnology subindustry, Orphazyme AS's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orphazyme AS's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's Quick Ratio falls into.



Orphazyme AS Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Orphazyme AS's Quick Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Quick Ratio (A: Dec. 2021 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(158.944-0)/129.092
=1.23

Orphazyme AS's Quick Ratio for the quarter that ended in Jun. 2022 is calculated as

Quick Ratio (Q: Jun. 2022 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(88.089-0)/15.384
=5.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orphazyme AS  (OCSE:ORPHA) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Orphazyme AS Quick Ratio Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orphazyme AS (OCSE:ORPHA) Business Description

Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (OCSE:ORPHA) Headlines

No Headlines